OPAM Workshop: Medical Review Officer Training Course: Toxicology Testing and the MRO, A Physician's Role in the Prevention and Treatment of Substance Abuse-285274

Video Transcription

Video Summary

The course aims to update participants on the latest federally mandated guidelines for Medical Review Officers (MROs). It highlights the importance of following updated procedures due to changes in regulations, particularly post-2017, marked in blue within the course materials. Key topics cover the integration of SAMHSA guidelines into DOT regulations, including recent updates for opioid testing, yet notably excluding fentanyl. The course outlines the move towards oral fluid testing, pending FDA device approvals and lab certifications, anticipated for rollout not before 2024.<br /><br />Emphasis is placed on comprehensive documentation and the need for MROs to understand both the clinical and forensic aspects of drug testing, crucial for ensuring integrity and accuracy in the process. Detailed guidelines on contacting donors, verifying test results, and handling various test outcomes are provided. Newly allowed procedures, such as MRO staff contacting pharmacies for verification, represent significant updates. Additionally, the course underscores the non-negotiable nature of maintaining a separation from personal relationships with laboratories to avoid conflicts of interest. Participants are encouraged to engage with course instructors for clarifications and to utilize provided resources effectively to prepare for exams.

Keywords

Medical Review Officers

federally mandated guidelines

SAMHSA guidelines

DOT regulations

opioid testing updates

oral fluid testing

clinical and forensic drug testing

conflict of interest

pharmacy verification